Compare ResMed Inc. (RMD) vs T-Mobile Us Inc (TMUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs T-Mobile Us Inc — how do they compare? ResMed Inc. trades at $230.05 (market cap $31.89B), while T-Mobile Us Inc trades at $148.58 (market cap $183.76B). The key difference: T-Mobile Us Inc is far larger — about 5.8× ResMed Inc.'s market cap, and T-Mobile Us Inc pays the higher dividend (2.73%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and T-Mobile Us Inc for 84 Days on average.
| RMD | TMUS | |
|---|---|---|
Market Cap | $31.89B | $183.76B |
Volume | 618,314 | 4,294,650 |
Sector | Health | Media |
52-Week High | $275.96 | $230.06 |
52-Week Low | $182.82 | $148.58 |
Typical Hold Time | 51 Days | 84 Days |
Enterprise Value | $31.24B | $300.37B |
Dividend Yield | 1.16% | 2.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $226.73, up 0.33% on the day, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming earnings report and positive analyst commentary on growth prospects.
The outlook is positive, driven by consistent earnings outperformance and a consensus price target of $242.70, implying upside. Key risks include competitive pressures and ongoing legal investigations. Institutional interest remains strong, with recent stake increases by funds. The stock's valuation metrics, such as a P/E of 21.74, appear reasonable given growth expectations.
TMUS trades at $171.31, up 2.2% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $88.31B in 2025, with a net income margin of 11.45%, while the company announced a 15% dividend hike and AI-driven 5G network enhancements. Analyst consensus is strongly bullish with a $231.10 price target, though debt levels and competitive pressures remain considerations.
The outlook for TMUS is positive, driven by robust cash flow, strategic investments in network resilience, and favorable analyst sentiment. Key risks include high debt exposure and industry competition, but strong fundamentals and growth initiatives support a constructive view for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About T-Mobile Us Inc
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, creating T-Mobile Us. Following the merger, the firm provided nationwide service in major markets but spottier coverage elsewhere. T-Mobile spent aggressively on low-frequency spectrum, well suited to broad coverage, and has substantially expanded its geographic footprint. This expansion, coupled with aggressive marketing and innovative offerings, produced rapid customer growth. With the Sprint acquisition, the firm's scale now roughly matches its larger rivals: T-Mobile now serves 71 million postpaid and 21 million prepaid phone customers, equal to around 30% of the U.S. retail wireless market. In addition, the firm provides wholesale service to resellers.
Read more on TMUS →
